Gitelman syndrome

Revisión del 11:31 19 mar 2026 de Danbot (discusión | contribs.) (Added DDX template transclusions: Hypokalemia, Hypomagnesemia, Metabolic alkalosis, Renal tubular disorders, Prolonged QT)
(difs.) ← Revisión anterior | Revisión actual (difs.) | Revisión siguiente → (difs.)

Background

  • Gitelman syndrome is an autosomal recessive salt-losing tubulopathy caused by loss-of-function mutations in the thiazide-sensitive sodium-chloride cotransporter (NCC) in the distal convoluted tubule[1]
  • It is the most common inherited renal tubulopathy (~1 in 40,000) and presents with hypokalemic metabolic alkalosis, hypomagnesemia, and hypocalciuria — biochemically identical to chronic thiazide diuretic use[2]
  • Usually diagnosed in adolescence or adulthood, it is generally benign but can cause life-threatening hypokalemia, cardiac arrhythmias, tetany, paralysis, and rhabdomyolysis
  • The EM physician encounters Gitelman syndrome as unexplained refractory hypokalemia in a young normotensive patient, tetany or muscle cramps, or cardiac arrhythmia from combined hypokalemia and hypomagnesemia
  • Prevalence ~1 in 40,000 (heterozygote carrier frequency ~1% in Caucasians); higher in Asian populations
  • Much more common than Bartter syndrome (~1 in 1,000,000)
  • Usually presents after age 6; most diagnosed in adolescence or adulthood — many patients are asymptomatic for years
  • Mimics chronic thiazide (HCTZ) use — the NCC cotransporter is the same target as thiazide diuretics
  • Sudden cardiac death has been reported from severe hypokalemia/hypomagnesemia[2]

Clinical Features

  • Many patients are asymptomatic — discovered incidentally on routine labs showing hypokalemia
  • Muscle cramps, weakness, fatigue — the most common complaints
  • Tetany, carpopedal spasm — from hypomagnesemia; especially during illness or with vomiting/diarrhea
  • Facial paresthesias — characteristic
  • Salt craving (sometimes intense; also craving sour foods)
  • Thirst, nocturia, polyuria (milder than Bartter)
  • Constipation
  • Low or normal blood pressure — despite elevated renin/aldosterone
  • Chondrocalcinosis — calcium pyrophosphate crystal deposition in joints (from chronic hypomagnesemia); may present with acute pseudogout-like joint pain and swelling[2]
  • Prolonged QT interval — present in ~50%; risk of ventricular arrhythmias
  • Severe presentations (uncommon): hypokalemic paralysis (especially in Asian populations), rhabdomyolysis, seizures, ventricular arrhythmia/cardiac arrest

Differential Diagnosis

  • Bartter syndrome: the key differential — more severe, earlier onset, hypercalciuria (vs hypocalciuria in Gitelman), mimics loop diuretic (vs thiazide); see comparison table on Bartter syndrome page
  • Surreptitious vomiting / bulimia: urine chloride <25 mEq/L (Gitelman: urine Cl >35 mEq/L)
  • Thiazide diuretic use/abuse: identical lab picture — screen urine for diuretics
  • Laxative abuse: low urine potassium (renal potassium wasting distinguishes Gitelman)
  • Primary hyperaldosteronism: hypertension present (Gitelman is normotensive/hypotensive)
  • Renal tubular acidosis: metabolic acidosis (not alkalosis)
  • Hypomagnesemia from other causes: PPI use, alcoholism, aminoglycosides, cisplatin — check medication history
  • Pseudogout (if presenting with chondrocalcinosis): check electrolytes in any young patient with calcium pyrophosphate arthropathy — may unmask Gitelman

Hypokalemia

Hypomagnesemia

Metabolic alkalosis

Renal tubular disorders

  • Salt-wasting tubulopathies
    • Gitelman syndrome — distal convoluted tubule (NCC defect); hypokalemia, hypomagnesemia, hypocalciuria, metabolic alkalosis
    • Bartter syndrome — thick ascending limb (NKCC2/ROMK/ClC-Kb defect); hypokalemia, hypercalciuria, metabolic alkalosis
    • Liddle syndrome — collecting duct (ENaC gain-of-function); hypokalemia, hypertension, metabolic alkalosis
  • Renal tubular acidosis
  • Inherited disorders of tubular transport
    • Cystinuria — proximal tubule amino acid transport defect; recurrent cystine stones
    • Fanconi syndrome — proximal tubule generalized dysfunction; glucosuria, aminoaciduria, phosphaturia
    • Nephrogenic diabetes insipidus — collecting duct (aquaporin/V2R defect); polyuria, hypernatremia
    • Dent disease — proximal tubule (ClC-5 defect); low molecular weight proteinuria, nephrocalcinosis
  • Acquired tubulopathies

Evaluation

Workup

  • BMP: hypokalemia (often 2.5-3.0 mEq/L), hypochloremia, elevated bicarbonate (metabolic alkalosis)
  • Magnesium: low (<1.6 mg/dL) in most patients — always check magnesium when you find hypokalemia
  • Urine electrolytes:
    • Urine chloride >35 mEq/L — confirms renal salt wasting (excludes vomiting)
    • Urine potassium elevated (inappropriate renal K wasting)
    • Urine calcium:creatinine ratio LOW (hypocalciuria) — the key distinction from Bartter (which has hypercalciuria)
  • ECG: prolonged QT, flattened T waves, U waves, ST depression; assess for arrhythmia

Prolonged QT interval

  • Urine drug screen for diuretics — must exclude thiazide abuse before diagnosing Gitelman

Diagnosis

  • Hypokalemic hypochloremic metabolic alkalosis + hypomagnesemia + hypocalciuria + normal/low BP + urine Cl >35 = Gitelman pattern
  • Exclude vomiting (urine Cl <25), diuretic abuse (urine drug screen), and medications causing hypomagnesemia
  • Genetic testing (SLC12A3 mutations) is confirmatory but not an ED test
  • Clinical and biochemical diagnosis is sufficient to initiate treatment

Management

  • Correct hypokalemia:
    • IV KCl for severe hypokalemia (<2.5 mEq/L), ECG changes, or arrhythmias
    • Oral KCl for mild-moderate cases
    • Correct hypomagnesemia FIRST — magnesium deficiency causes refractory hypokalemia that will not correct until magnesium is repleted[1]
  • Correct hypomagnesemia:
    • IV magnesium sulfate (2 g over 15-30 min, then infusion) for severe hypomagnesemia, tetany, or arrhythmias
    • Oral magnesium supplementation for chronic management (magnesium oxide, magnesium citrate)
    • GI side effects (diarrhea) limit oral magnesium dosing — a major compliance issue
  • Cardiac monitoring: continuous telemetry if K <3.0 mEq/L, prolonged QT, or any arrhythmia
  • Continue home medications: potassium-sparing diuretics (amiloride, spironolactone), oral potassium and magnesium supplements — do NOT discontinue
  • Do NOT use thiazide diuretics — this worsens the underlying defect
  • NSAIDs (indomethacin): sometimes used chronically as adjunctive therapy (reduces prostaglandin-mediated salt wasting) — continue if prescribed
  • Treat precipitating illness: any condition causing vomiting, diarrhea, or fever can precipitate electrolyte crisis in Gitelman patients

Disposition

  • Admit:
    • Severe hypokalemia (<2.5 mEq/L) or symptomatic hypokalemia (arrhythmia, paralysis, rhabdomyolysis)
    • Tetany or seizures
    • QT prolongation with arrhythmia
    • Unable to tolerate oral supplements
  • Discharge with close follow-up:
    • Mild-moderate hypokalemia correctable with oral supplements
    • No cardiac symptoms or ECG abnormalities
    • Tolerating PO
    • Nephrology follow-up within 1-2 weeks
  • New diagnosis suspected (unexplained hypokalemic alkalosis + hypomagnesemia + hypocalciuria in a normotensive patient): arrange nephrology referral for confirmation and long-term management
  • Counsel patients: liberal salt intake; high-potassium foods; take magnesium and potassium supplements reliably; seek care promptly during illness (vomiting/diarrhea can precipitate dangerous electrolyte drops); report palpitations, weakness, or muscle spasms immediately

See Also

External Links

References

  1. ↑ 1.0 1.1 Gitelman Syndrome. StatPearls. NCBI. 2024.
  2. ↑ 2.0 2.1 2.2 Gitelman syndrome: consensus and guidance from a KDIGO Controversies Conference. Kidney Int. 2017;91(1):24-33.
Obtenido de «https://www.wikem.org/w/index.php?title=Gitelman_syndrome&oldid=386191»